Aimmune Therapeutics
Industry: Biotechnology company
DescriptionHeadquarters: Brisbane, CA Chief medical officer: Daniel C. Adelman CFO: Eric Bjerkholt Founded: 2011 SVPs: Becki Filice,
Aimmune Therapeutics List of Employees There's an exhaustive list of past and present employees! Get comprehensive information on the number of employees at Aimmune Therapeutics. You can filter them based on skills, years of employment, job, education, department, and prior employment.
Aimmune Therapeutics Salaries. You can even request information on how much does Aimmune Therapeutics pay if you want to. Learn about salaries, pros and cons of working for Aimmune Therapeutics directly from the past employees.
Find People by Employers You can rekindle an old relationship, reconnect with a long-lost friend, former boss, business acquaintance who might be useful in your new line of work. With our employee database, the possibilities are endless. All you have to do is type in a couple of keywords and we'll bring you the exact information you wanted!
13 Aimmune Therapeutics employees in database. Find out everything there's to know about Aimmune Therapeutics employees. We offer you a great deal of unbiased information from the internal database, personal records, and many other details that might be of interest to you.
Aimmune Therapeutics Employees
Employee
Years
Job
Industry
Nancy Alexi Nancy Alexi's Aimmune Therapeutics Experience May 2015 - Present
Job Director, Project Management at Aimmune Therapeutics
Industry Biotechnology
Experience
Aimmune Therapeutics May 2015 - Present
Skills
Cancer, Therapeutic Areas, Biologics, Small Molecules, Lupus, Biotechnology, Chronic Kidney Disease, Clinical Development, Lifesciences, Pharmaceutical Industry, Drug Discovery, Biopharmaceuticals, Technology Transfer, Molecular Biology, Biochemistry, GLP, GMP, Change Control, Validation, Cross-functional Team..., Drug Development, CRO, GCP, Project Management, Life Sciences, FDA, Clinical Trials, SOP, Regulatory Submissions, Oncology, Process Improvement, Purification, 21 CFR Part 11, IND, Medical Devices, Strategy, Leadership, R, Clinical Research, Management
Education
University of Reading 1987 — 2001
Ph.D.
University of Kent 1984 — 1987
B.Sc. (Hons)
Micklefield school 1980 — 1984
Aimmune Therapeutics May 2015 - Present
Skills
Cancer, Therapeutic Areas, Biologics, Small Molecules, Lupus, Biotechnology, Chronic Kidney Disease, Clinical Development, Lifesciences, Pharmaceutical Industry, Drug Discovery, Biopharmaceuticals, Technology Transfer, Molecular Biology, Biochemistry, GLP, GMP, Change Control, Validation, Cross-functional Team..., Drug Development, CRO, GCP, Project Management, Life Sciences, FDA, Clinical Trials, SOP, Regulatory Submissions, Oncology, Process Improvement, Purification, 21 CFR Part 11, IND, Medical Devices, Strategy, Leadership, R, Clinical Research, Management
Education
University of Reading 1987 — 2001
Ph.D.
University of Kent 1984 — 1987
B.Sc. (Hons)
Micklefield school 1980 — 1984
Kate Falberg Kate Falberg's Aimmune Therapeutics Experience May 2015 - Present
Job Chairman of Board, Audit Committee Chair at multiple Life Sciences Companies
Industry Executive Office
Experience
Aimmune Therapeutics May 2015 - Present
aTyr Pharma June 2014 - Present
Medivation February 2013 - Present
Halozyme Therapeutics, Inc. May 2007 - Present
Ariosa Diagnostics April 2014 - January 2015
Jazz Pharmaceuticals December 2009 - March 2014
Amgen 1995 - 2001
Skills
Finance, Mergers, Start-ups, Due Diligence, Financial Modeling, Strategic Planning, Business Strategy, Cross-functional Team..., Forecasting, Financial Reporting, Budgets, Process Improvement, Financial Analysis, Product Development, Business Planning, Managerial Finance, Change Management, Risk Management, Biotechnology, Management, Mergers & Acquisitions, Business Development, Strategy, Valuation, Sarbanes-Oxley Act, Corporate Finance, Corporate Development, Accounting, Pharmaceutical Industry, Venture Capital, Contract Negotiation, Commercialization, Auditing, Executive Management, Portfolio Management, Acquisition Integration, Leadership, Management Consulting, Strategic Financial..., SAP
Education
University of California, Los Angeles - The Anderson School of Management 1983 — 1984
Master of Business Administration (MBA), Finance
University of California, Los Angeles 1977 — 1981
Bachelor of Arts (B.A.), Economics
Aimmune Therapeutics May 2015 - Present
aTyr Pharma June 2014 - Present
Medivation February 2013 - Present
Halozyme Therapeutics, Inc. May 2007 - Present
Ariosa Diagnostics April 2014 - January 2015
Jazz Pharmaceuticals December 2009 - March 2014
Amgen 1995 - 2001
Skills
Finance, Mergers, Start-ups, Due Diligence, Financial Modeling, Strategic Planning, Business Strategy, Cross-functional Team..., Forecasting, Financial Reporting, Budgets, Process Improvement, Financial Analysis, Product Development, Business Planning, Managerial Finance, Change Management, Risk Management, Biotechnology, Management, Mergers & Acquisitions, Business Development, Strategy, Valuation, Sarbanes-Oxley Act, Corporate Finance, Corporate Development, Accounting, Pharmaceutical Industry, Venture Capital, Contract Negotiation, Commercialization, Auditing, Executive Management, Portfolio Management, Acquisition Integration, Leadership, Management Consulting, Strategic Financial..., SAP
Education
University of California, Los Angeles - The Anderson School of Management 1983 — 1984
Master of Business Administration (MBA), Finance
University of California, Los Angeles 1977 — 1981
Bachelor of Arts (B.A.), Economics
Dennis Bittner Dennis Bittner's Aimmune Therapeutics Experience May 2015 - August 2015
Job Regulatory Medical Writer at Nektar Therapeutics
Industry Writing and Editing
Experience
Nektar Therapeutics August 2015 - Present
Regulatory Writing, Scientific Editing, Technical Writing June 2013 - Present
Aimmune Therapeutics May 2015 - August 2015
American Association of Cancer Research March 2015 - July 2015
Abbott February 2015 - May 2015
Clinovo February 2015 - May 2015
Emma Hitt Medical Writing February 2014 - December 2014
InClin, Inc April 2014 - November 2014
Roche Molecular Systems May 2014 - October 2014
Dynavax Technologies January 2014 - April 2014
Skills
Medical Writing, Technical Writing, FDA, Regulatory Submissions, Oncology, Medical Devices, Regulatory Affairs, Clinical Trials, Clinical Development, Clinical Research, Lifesciences, Biotechnology, Biopharmaceuticals, Pharmaceutical Industry, R&D, Genomics, Business Development, Proteomics, Molecular Biology, Biochemistry, Immunology, Product Management, Product Development, Management, Genetics, cGMP practices, Sales, Commercialization, Chromatography, qPCR, DNA, Marketing, PCR, Drug Discovery, HPLC, ELISA, Sales Management, Cell Biology, Technology Transfer, Infectious Diseases, Microbiology, Molecular Diagnostics, Immunoassays, Protein Purification, Assay Development, Validation, Medical Diagnostics, Product Launch, Life Sciences, CRO
Education
University of California, Los Angeles 1987 — 1993
Ph.D., Biological Chemistry
University of California, Los Angeles 1983 — 1987
B.S., Molecular, Cellular, and Developmental Biology
UC Berkeley Extension 2014 — 2014
Nektar Therapeutics August 2015 - Present
Regulatory Writing, Scientific Editing, Technical Writing June 2013 - Present
Aimmune Therapeutics May 2015 - August 2015
American Association of Cancer Research March 2015 - July 2015
Abbott February 2015 - May 2015
Clinovo February 2015 - May 2015
Emma Hitt Medical Writing February 2014 - December 2014
InClin, Inc April 2014 - November 2014
Roche Molecular Systems May 2014 - October 2014
Dynavax Technologies January 2014 - April 2014
Skills
Medical Writing, Technical Writing, FDA, Regulatory Submissions, Oncology, Medical Devices, Regulatory Affairs, Clinical Trials, Clinical Development, Clinical Research, Lifesciences, Biotechnology, Biopharmaceuticals, Pharmaceutical Industry, R&D, Genomics, Business Development, Proteomics, Molecular Biology, Biochemistry, Immunology, Product Management, Product Development, Management, Genetics, cGMP practices, Sales, Commercialization, Chromatography, qPCR, DNA, Marketing, PCR, Drug Discovery, HPLC, ELISA, Sales Management, Cell Biology, Technology Transfer, Infectious Diseases, Microbiology, Molecular Diagnostics, Immunoassays, Protein Purification, Assay Development, Validation, Medical Diagnostics, Product Launch, Life Sciences, CRO
Education
University of California, Los Angeles 1987 — 1993
Ph.D., Biological Chemistry
University of California, Los Angeles 1983 — 1987
B.S., Molecular, Cellular, and Developmental Biology
UC Berkeley Extension 2014 — 2014
Curtis A. Murray, MBA Curtis A. Murray, MBA's Aimmune Therapeutics Experience March 2013 - September 2013
Job Medical and Scientific Affairs Sr. Operations Associate at Onyx Pharmaceuticals
Industry Biotechnology
Experience
Onyx Pharmaceuticals February 2014 - Present
Aimmune Therapeutics March 2013 - September 2013
Ipsen July 2009 - January 2012
Genentech October 2008 - July 2009
Medco 2004 - 2008
Skills
Task Management, Resource Management, Project Planning, MS Project, Project Execution, Team Leadership, Business Analysis, Healthcare Reimbursement, Medicare/Medicaid..., Project Management, Managed Care, Process Improvement, Management, Leadership, Endocrinology, Biotechnology, Vendor Management, Healthcare, Customer Service, Pharmaceutical Industry, Cross-functional Team..., Oncology, Clinical Research, Clinical Trials, Life Sciences, GCP, Competitive Analysis, Fair Market Value, Contract Negotiation, Contractual Agreements, Oncology Clinical..., International Business, Budget Management, Operations Management, Budget Reconciliation, Budget Analysis, Clinical Support
Education
Christian Brothers University 2005 — 2007
MBA, Project Management
University of Mississippi - School of Business Administration
BBA, Finance
Onyx Pharmaceuticals February 2014 - Present
Aimmune Therapeutics March 2013 - September 2013
Ipsen July 2009 - January 2012
Genentech October 2008 - July 2009
Medco 2004 - 2008
Skills
Task Management, Resource Management, Project Planning, MS Project, Project Execution, Team Leadership, Business Analysis, Healthcare Reimbursement, Medicare/Medicaid..., Project Management, Managed Care, Process Improvement, Management, Leadership, Endocrinology, Biotechnology, Vendor Management, Healthcare, Customer Service, Pharmaceutical Industry, Cross-functional Team..., Oncology, Clinical Research, Clinical Trials, Life Sciences, GCP, Competitive Analysis, Fair Market Value, Contract Negotiation, Contractual Agreements, Oncology Clinical..., International Business, Budget Management, Operations Management, Budget Reconciliation, Budget Analysis, Clinical Support
Education
Christian Brothers University 2005 — 2007
MBA, Project Management
University of Mississippi - School of Business Administration
BBA, Finance
Peter Heinecke's Aimmune Therapeutics Experience July 2015 - Present
Job Acting General Counsel at Aimmune Therapeutics
Industry Biotechnology
Experience
Aimmune Therapeutics July 2015 - Present
Xalud Therapeutics, Inc. October 2010 - Present
Hill Street Advisors January 2007 - Present
Experimed Bioscience February 2007 - March 2011
Aviir, Inc. October 2005 - December 2006
Kirkpatrick & Lockhart LLP September 2003 - December 2005
Wilson Sonsini Goodrich & Rosati September 1994 - August 2003
Morgan Stanley & Co. July 1988 - June 1990
Skills
Venture Capital, Mergers, Venture Financing, Corporate Development, Start-ups, Due Diligence, Mergers & Acquisitions, Strategic Partnerships, Commercialization, Private Equity, Licensing, Lifesciences, Intellectual Property, Strategy, Entrepreneurship, Management, Biotechnology, IPO, Finance, Joint Ventures, Life Sciences
Education
University of Chicago 1990 — 1994
JD/MBA
Princeton University 1983 — 1987
AB, Politics
Aimmune Therapeutics July 2015 - Present
Xalud Therapeutics, Inc. October 2010 - Present
Hill Street Advisors January 2007 - Present
Experimed Bioscience February 2007 - March 2011
Aviir, Inc. October 2005 - December 2006
Kirkpatrick & Lockhart LLP September 2003 - December 2005
Wilson Sonsini Goodrich & Rosati September 1994 - August 2003
Morgan Stanley & Co. July 1988 - June 1990
Skills
Venture Capital, Mergers, Venture Financing, Corporate Development, Start-ups, Due Diligence, Mergers & Acquisitions, Strategic Partnerships, Commercialization, Private Equity, Licensing, Lifesciences, Intellectual Property, Strategy, Entrepreneurship, Management, Biotechnology, IPO, Finance, Joint Ventures, Life Sciences
Education
University of Chicago 1990 — 1994
JD/MBA
Princeton University 1983 — 1987
AB, Politics
Yuki Mathias's Aimmune Therapeutics Experience April 2014 - Present
Job Senior CRA at Aimmune Therapeutics, Inc
Industry Biotechnology
Experience
Aimmune Therapeutics April 2014 - Present
Dynavax Technologies January 2014 - July 2015
Theravance 2008 - 2011
i3 Research 2006 - 2007
Kforce 2005 - 2006
Chiron 2000 - 2005
Ecology Center 1991 - 1999
Skills
Clinical Research, CRO, EDC, GCP, Clinical Development, Infectious Diseases, Clinical Trials, Endocrinology, Vaccines, Drug Development, Clinical Monitoring, CTMS, Pharmaceutical Industry, Clinical Study Design, Biotechnology, Protocol, ICH-GCP, Clinical Data Management, Therapeutic Areas, Regulatory Submissions, Oncology, Immunology, Medical Affairs, Ophthalmology, IND, Sop, Regulatory Affairs, Biopharmaceuticals, Regulatory Requirements, FDA, SOP
Education
University of California, Berkeley 1989 — 1993
BS, Conservation & Resource Studies
Aimmune Therapeutics April 2014 - Present
Dynavax Technologies January 2014 - July 2015
Theravance 2008 - 2011
i3 Research 2006 - 2007
Kforce 2005 - 2006
Chiron 2000 - 2005
Ecology Center 1991 - 1999
Skills
Clinical Research, CRO, EDC, GCP, Clinical Development, Infectious Diseases, Clinical Trials, Endocrinology, Vaccines, Drug Development, Clinical Monitoring, CTMS, Pharmaceutical Industry, Clinical Study Design, Biotechnology, Protocol, ICH-GCP, Clinical Data Management, Therapeutic Areas, Regulatory Submissions, Oncology, Immunology, Medical Affairs, Ophthalmology, IND, Sop, Regulatory Affairs, Biopharmaceuticals, Regulatory Requirements, FDA, SOP
Education
University of California, Berkeley 1989 — 1993
BS, Conservation & Resource Studies
Sri Ryali's Aimmune Therapeutics Experience 2015 - Present
Job Senior Director, Finance at Aimmune Therapeutics
Industry Biotechnology
Experience
Aimmune Therapeutics 2015 - Present
Jazz Pharmaceuticals 2015 - 2015
Onyx Pharmaceuticals 2011 - 2015
Amgen 2004 - 2011
The Walt Disney Company 2004 - 2004
Baxter Healthcare 2003 - 2004
Skills
Financial Modeling, Corporate Finance, Forecasting, Financial Analysis, Biotechnology, Budgets, Finance, Due Diligence, Mergers & Acquisitions, Cross-functional Team..., Financial Reporting, Capital Budgeting, Acquisition Integration, Strategic Financial..., Valuation, Pharmaceutical Industry, Competitive Analysis, Analysis, Managerial Finance, Revenue Recognition, Strategic Planning, Accounting, Process Improvement, Strategy, Business Valuation, Corporate Development, Internal Controls, SEC filings, Executive Management, Variance Analysis, Start-ups, Sarbanes-Oxley Act, Consolidation, Business Planning, US GAAP, Investor Relations
Education
UCLA Anderson School of Management
Master of Business Administration (MBA)
UCLA
Bachelor of Arts (B.A.), Double Major in Economics and Microbiology, Immunology & Molecular Genetics
Aimmune Therapeutics 2015 - Present
Jazz Pharmaceuticals 2015 - 2015
Onyx Pharmaceuticals 2011 - 2015
Amgen 2004 - 2011
The Walt Disney Company 2004 - 2004
Baxter Healthcare 2003 - 2004
Skills
Financial Modeling, Corporate Finance, Forecasting, Financial Analysis, Biotechnology, Budgets, Finance, Due Diligence, Mergers & Acquisitions, Cross-functional Team..., Financial Reporting, Capital Budgeting, Acquisition Integration, Strategic Financial..., Valuation, Pharmaceutical Industry, Competitive Analysis, Analysis, Managerial Finance, Revenue Recognition, Strategic Planning, Accounting, Process Improvement, Strategy, Business Valuation, Corporate Development, Internal Controls, SEC filings, Executive Management, Variance Analysis, Start-ups, Sarbanes-Oxley Act, Consolidation, Business Planning, US GAAP, Investor Relations
Education
UCLA Anderson School of Management
Master of Business Administration (MBA)
UCLA
Bachelor of Arts (B.A.), Double Major in Economics and Microbiology, Immunology & Molecular Genetics
Jerome Pinkett's Aimmune Therapeutics Experience July 2015 - Present
Job Director Clinical Operations at Aimmune Therapeutics
Industry Biotechnology
Experience
Aimmune Therapeutics July 2015 - Present
Principia Biopharma July 2013 - Present
Principia Biopharma July 2013 - Present
Revance 2009 - February 2010
Genitope 2004 - 2006
Shaman pharmaceuticals 1993 - 1995
Chiron 1991 - 1993
Skills
GCP, Cross-functional Team..., Clinical Development, Clinical Trials, Biotechnology, Oncology, FDA, Dermatology, EDC, CTMS, Clinical Operations, Management, Validation
Education
John F. Kennedy University 2002 — 2004
Master of Business Administration (MBA)
Aimmune Therapeutics July 2015 - Present
Principia Biopharma July 2013 - Present
Principia Biopharma July 2013 - Present
Revance 2009 - February 2010
Genitope 2004 - 2006
Shaman pharmaceuticals 1993 - 1995
Chiron 1991 - 1993
Skills
GCP, Cross-functional Team..., Clinical Development, Clinical Trials, Biotechnology, Oncology, FDA, Dermatology, EDC, CTMS, Clinical Operations, Management, Validation
Education
John F. Kennedy University 2002 — 2004
Master of Business Administration (MBA)
Joseph Suttner's Aimmune Therapeutics Experience November 2012 - Present
Job Vice President, Clinical Operations at Aimmune Therapeutics
Industry Pharmaceuticals
Experience
Aimmune Therapeutics November 2012 - Present
PhotoThera July 2012 - November 2012
Ipsen March 2011 - June 2012
Peplin Ltd September 2007 - April 2011
Skills
Clinical Development, Clinical Trials, Pharmaceutical Industry, Regulatory Submissions, Oncology, Biotechnology, Regulatory Affairs, Clinical Research, Dermatology, IND, FDA, Clinical Operations, CRO, GCP, CTMS, Immunology, Lifesciences, Medical Devices, EDC, Pharmaceutics, Therapeutic Areas, Drug Development, Biopharmaceuticals, Clinical Data Management, Pharmacovigilance, Protocol
Education
University of Liverpool 2006 — 2007
MBA, Business Administration, Management and Operations
California State University-Long Beach 1984 — 1989
BA
Aimmune Therapeutics November 2012 - Present
PhotoThera July 2012 - November 2012
Ipsen March 2011 - June 2012
Peplin Ltd September 2007 - April 2011
Skills
Clinical Development, Clinical Trials, Pharmaceutical Industry, Regulatory Submissions, Oncology, Biotechnology, Regulatory Affairs, Clinical Research, Dermatology, IND, FDA, Clinical Operations, CRO, GCP, CTMS, Immunology, Lifesciences, Medical Devices, EDC, Pharmaceutics, Therapeutic Areas, Drug Development, Biopharmaceuticals, Clinical Data Management, Pharmacovigilance, Protocol
Education
University of Liverpool 2006 — 2007
MBA, Business Administration, Management and Operations
California State University-Long Beach 1984 — 1989
BA
Kristin Bennett's Aimmune Therapeutics Experience August 2015 - Present
Job Senior Director, Commercial at Aimmune Therapeutics
Industry Pharmaceuticals
Experience
Aimmune Therapeutics August 2015 - Present
Sarepta Therapeutics November 2013 - August 2015
Vertex Pharmaceuticals October 2010 - November 2013
Acorda Therapeutics October 2009 - October 2010
Gilead Sciences 1999 - 2009
Gilead Sciences 2001 - 2004
Gilead Sciences 1999 - 2001
Roche Pharmaceuticals 1997 - 1999
Skills
Pharmaceutical Sales, Gastroenterology, Infectious Diseases, Biotechnology, Endocrinology, Pharmaceutical Industry, Cardiology, Managed Care, Immunology, Clinical Trials, Cross-functional Team..., Internal Medicine, Training, Territory Management, Pulmonology, Hospital Sales, Healthcare, Hospitals, Sales Operations, Sales Force Development, OB/GYN, Product Launch, Social Media Marketing, Marketing, Marketing Strategy
Education
California Polytechnic State University-San Luis Obispo 1988 — 1993
BS Nutrition Sciences, Business, Nutrition, French
Sorbonne University 1990 — 1991
Diplome French Studies, French Studies
Aimmune Therapeutics August 2015 - Present
Sarepta Therapeutics November 2013 - August 2015
Vertex Pharmaceuticals October 2010 - November 2013
Acorda Therapeutics October 2009 - October 2010
Gilead Sciences 1999 - 2009
Gilead Sciences 2001 - 2004
Gilead Sciences 1999 - 2001
Roche Pharmaceuticals 1997 - 1999
Skills
Pharmaceutical Sales, Gastroenterology, Infectious Diseases, Biotechnology, Endocrinology, Pharmaceutical Industry, Cardiology, Managed Care, Immunology, Clinical Trials, Cross-functional Team..., Internal Medicine, Training, Territory Management, Pulmonology, Hospital Sales, Healthcare, Hospitals, Sales Operations, Sales Force Development, OB/GYN, Product Launch, Social Media Marketing, Marketing, Marketing Strategy
Education
California Polytechnic State University-San Luis Obispo 1988 — 1993
BS Nutrition Sciences, Business, Nutrition, French
Sorbonne University 1990 — 1991
Diplome French Studies, French Studies
Alexandra Cocleaza's Aimmune Therapeutics Experience July 2015 - Present
Job
Industry Biotechnology
Experience
Aimmune Therapeutics July 2015 - Present
Skills
Investment Banking, Research, Business Strategy, Financial Modeling, Microsoft Office, Market Research, Financial Analysis, Capital Markets, Life Sciences, Healthcare, Due Diligence, Mergers & Acquisitions, Analysis, Valuation, Finance, Corporate Finance, Data Analysis
Education
Yale University 2008 — 2012
Bachelor of Arts (B.A.) with Distinction
Universität Konstanz 2010 — 2010
German language program
Aimmune Therapeutics July 2015 - Present
Skills
Investment Banking, Research, Business Strategy, Financial Modeling, Microsoft Office, Market Research, Financial Analysis, Capital Markets, Life Sciences, Healthcare, Due Diligence, Mergers & Acquisitions, Analysis, Valuation, Finance, Corporate Finance, Data Analysis
Education
Yale University 2008 — 2012
Bachelor of Arts (B.A.) with Distinction
Universität Konstanz 2010 — 2010
German language program
Amy Douglas's Aimmune Therapeutics Experience October 2013 - Present
Job Sr. CRA Aimmune Therapeutics
Industry Pharmaceuticals
Experience
Aimmune Therapeutics October 2013 - Present
Clinical Research Associates January 2012 - October 2013
U-Systems, A GE Healthcare Company 2012 - 2013
Direct Flow Medical®, Inc. 2012 - 2012
Santen January 2010 - June 2011
Advanced Clinical Services, U-Systems January 2010 - May 2010
MDS Pharma Services 2004 - 2009
First Databank (FDB) September 2002 - January 2004
Costco Wholesale January 1996 - 2003
Skills
CRO, GCP, Clinical Monitoring, EDC, CTMS, Clinical Research, Laboratory, Report Writing, Medical Devices, Medical Terminology, Research Design, Project Management, Program Management, Clinical Trials, Clinical Study Design, ICH-GCP, Protocol, FDA, Clinical Development, Clinical Data Management, Drug Development, Pharmaceutical Industry, Sop, 21 CFR Part 11, Clinical Operations, Therapeutic Areas, Diabetes, Data Management, Oracle Clinical, CRF design, SOP
Education
Sonoma State University 2001 — 2003
Bachelor of Arts (BA), Biology, General
Santa Rosa Junior College
Aimmune Therapeutics October 2013 - Present
Clinical Research Associates January 2012 - October 2013
U-Systems, A GE Healthcare Company 2012 - 2013
Direct Flow Medical®, Inc. 2012 - 2012
Santen January 2010 - June 2011
Advanced Clinical Services, U-Systems January 2010 - May 2010
MDS Pharma Services 2004 - 2009
First Databank (FDB) September 2002 - January 2004
Costco Wholesale January 1996 - 2003
Skills
CRO, GCP, Clinical Monitoring, EDC, CTMS, Clinical Research, Laboratory, Report Writing, Medical Devices, Medical Terminology, Research Design, Project Management, Program Management, Clinical Trials, Clinical Study Design, ICH-GCP, Protocol, FDA, Clinical Development, Clinical Data Management, Drug Development, Pharmaceutical Industry, Sop, 21 CFR Part 11, Clinical Operations, Therapeutic Areas, Diabetes, Data Management, Oracle Clinical, CRF design, SOP
Education
Sonoma State University 2001 — 2003
Bachelor of Arts (BA), Biology, General
Santa Rosa Junior College
Lupe Villagomez's Aimmune Therapeutics Experience 2015 - Present
Job Clinical Operations at Aimmune Therapeutics
Industry Biotechnology
Experience
Aimmune Therapeutics 2015 - Present
Onyx Pharmaceuticals September 2012 - March 2015
Genentech October 2006 - September 2012
Genentech October 2003 - October 2006
Titan Pharmaceuticals April 2002 - October 2003
Chiron Corporation June 2001 - April 2002
Quintiles May 1999 - May 2001
Education
Universidad Michoacana de San Nicolás de Hidalgo
Aimmune Therapeutics 2015 - Present
Onyx Pharmaceuticals September 2012 - March 2015
Genentech October 2006 - September 2012
Genentech October 2003 - October 2006
Titan Pharmaceuticals April 2002 - October 2003
Chiron Corporation June 2001 - April 2002
Quintiles May 1999 - May 2001
Education
Universidad Michoacana de San Nicolás de Hidalgo
Amgen
Biogen Idec
Gilead Sciences
Celgene
Biogen
Amgen Inc
bioMerieux
Centocor